07.20.11
In an effort to expand its offerings for infusion therapy in both the acute care hospital and outpatient markets, with an initial focus on home infusion, B. Braun Medical Inc. has inked five-year distribution agreement with CME America to distribute its BodyGuard line of electronic infusion pumps.
"B. Braun's collaboration and synergy with CME America further demonstrates our commitment to bringing our customers infusion therapy systems that address key home infusion therapy needs, such as flexibility and a wide-range of programming options, while remaining cost-effective," said Eric Melanson, director of Marketing for Infusion Systems, B. Braun Medical Inc. "Strong hallmarks of the BodyGuard product portfolio include wide capabilities in therapy settings, a host of green power options, and an on-pump history capability."
B. Braun's customers will have access to the full line of BodyGuard electronic infusion pumps, including these four pump models:
* BodyGuard 323 multi-therapy pump: Programmable in five modes (continuous, intermittent, TPN, PCA and 25-Step) to deliver antibiotics, chemotherapy, parenteral and enteral nutrition fluids, analgesics and patient-controlled analgesia (PCA). Flexible configuration allows for pole-mounted use and a carrying pouch for home care;
* BodyGuard 545 epidural pump: Specially designed and color-coded for epidural medication infusion
* BodyGuard 575 PCA pump delivers continuous, bolus and clinician-activated bolus infusions for PCA; and
* BodyGuard 121 (Twins) pump: A two-channel pump designed for hospital and home use when administering more than one medication.
CME America, LLC is a medical device manufacturer in Golden, Colo. CME infusion pumps and syringe systems have been used in hospitals, clinics and patients' homes.
Germany-based B. Braun has its U.S. headquarters in Bethlehem, Pa.
"B. Braun's collaboration and synergy with CME America further demonstrates our commitment to bringing our customers infusion therapy systems that address key home infusion therapy needs, such as flexibility and a wide-range of programming options, while remaining cost-effective," said Eric Melanson, director of Marketing for Infusion Systems, B. Braun Medical Inc. "Strong hallmarks of the BodyGuard product portfolio include wide capabilities in therapy settings, a host of green power options, and an on-pump history capability."
B. Braun's customers will have access to the full line of BodyGuard electronic infusion pumps, including these four pump models:
* BodyGuard 323 multi-therapy pump: Programmable in five modes (continuous, intermittent, TPN, PCA and 25-Step) to deliver antibiotics, chemotherapy, parenteral and enteral nutrition fluids, analgesics and patient-controlled analgesia (PCA). Flexible configuration allows for pole-mounted use and a carrying pouch for home care;
* BodyGuard 545 epidural pump: Specially designed and color-coded for epidural medication infusion
* BodyGuard 575 PCA pump delivers continuous, bolus and clinician-activated bolus infusions for PCA; and
* BodyGuard 121 (Twins) pump: A two-channel pump designed for hospital and home use when administering more than one medication.
CME America, LLC is a medical device manufacturer in Golden, Colo. CME infusion pumps and syringe systems have been used in hospitals, clinics and patients' homes.
Germany-based B. Braun has its U.S. headquarters in Bethlehem, Pa.